258 related articles for article (PubMed ID: 19628421)
1. Overexpression and activation of Akt2 protein in oral squamous cell carcinoma.
Iamaroon A; Krisanaprakornkit S
Oral Oncol; 2009 Oct; 45(10):e175-9. PubMed ID: 19628421
[TBL] [Abstract][Full Text] [Related]
2. Specific inhibition of AKT2 by RNA interference results in reduction of ovarian cancer cell proliferation: increased expression of AKT in advanced ovarian cancer.
Noske A; Kaszubiak A; Weichert W; Sers C; Niesporek S; Koch I; Schaefer B; Sehouli J; Dietel M; Lage H; Denkert C
Cancer Lett; 2007 Feb; 246(1-2):190-200. PubMed ID: 16584837
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of T-cadherin inhibits the proliferation of oral squamous cell carcinoma through the PI3K/AKT/mTOR intracellular signalling pathway.
Wang Q; Zhang X; Song X; Zhang L
Arch Oral Biol; 2018 Dec; 96():74-79. PubMed ID: 30195142
[TBL] [Abstract][Full Text] [Related]
4. Akt2 and p-Akt overexpression in oral cancer cells is due to a reduced rate of protein degradation.
Archewa P; Pata S; Chotjumlong P; Supanchart C; Krisanaprakornkit S; Iamaroon A
J Investig Clin Dent; 2017 Feb; 8(1):. PubMed ID: 26393327
[TBL] [Abstract][Full Text] [Related]
5. Akt-FOXO3a signaling axis dysregulation in human oral squamous cell carcinoma and potent efficacy of FOXO3a-targeted gene therapy.
Fang L; Wang H; Zhou L; Yu D
Oral Oncol; 2011 Jan; 47(1):16-21. PubMed ID: 21109483
[TBL] [Abstract][Full Text] [Related]
6. AKT involvement in cisplatin chemoresistance of human uterine cancer cells.
Gagnon V; Mathieu I; Sexton E; Leblanc K; Asselin E
Gynecol Oncol; 2004 Sep; 94(3):785-95. PubMed ID: 15350374
[TBL] [Abstract][Full Text] [Related]
7. Correlation between the expression of Id-1 and hyperthermia-associated molecules in oral squamous cell carcinoma.
Zhao J; Wang S; Liu N; Tang X
J Clin Pathol; 2013 Sep; 66(9):758-63. PubMed ID: 23723304
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of activated Akt expression in oral squamous cell carcinoma.
Lim J; Kim JH; Paeng JY; Kim MJ; Hong SD; Lee JI; Hong SP
J Clin Pathol; 2005 Nov; 58(11):1199-205. PubMed ID: 16254112
[TBL] [Abstract][Full Text] [Related]
9. NDRG2 is a candidate tumor-suppressor for oral squamous-cell carcinoma.
Furuta H; Kondo Y; Nakahata S; Hamasaki M; Sakoda S; Morishita K
Biochem Biophys Res Commun; 2010 Jan; 391(4):1785-91. PubMed ID: 20045673
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of 1D-myo-inositol 1,4,5-trisphosphate 3-kinase A protein expression in oral squamous cell carcinoma.
Kato H; Uzawa K; Onda T; Kato Y; Saito K; Nakashima D; Ogawara K; Bukawa H; Yokoe H; Tanzawa H
Int J Oncol; 2006 Apr; 28(4):873-81. PubMed ID: 16525636
[TBL] [Abstract][Full Text] [Related]
11. Identification of Akt1 as a potent therapeutic target for oral squamous cell carcinoma.
Nakashiro K; Tanaka H; Goda H; Iwamoto K; Tokuzen N; Hara S; Onodera J; Fujimoto I; Hino S; Hamakawa H
Int J Oncol; 2015 Oct; 47(4):1273-81. PubMed ID: 26315674
[TBL] [Abstract][Full Text] [Related]
12. MICA and MICB overexpression in oral squamous cell carcinoma.
Liu CJ; Lui MT; Chen HL; Lin SC; Chang KW
J Oral Pathol Med; 2007 Jan; 36(1):43-7. PubMed ID: 17181741
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation.
Yap LF; Jenei V; Robinson CM; Moutasim K; Benn TM; Threadgold SP; Lopes V; Wei W; Thomas GJ; Paterson IC
Oncogene; 2009 Jul; 28(27):2524-34. PubMed ID: 19448673
[TBL] [Abstract][Full Text] [Related]
14. Significance of Akt activation and AKT gene increases in soft tissue tumors.
Dobashi Y; Sato E; Oda Y; Inazawa J; Ooi A
Hum Pathol; 2014 Jan; 45(1):127-36. PubMed ID: 24321521
[TBL] [Abstract][Full Text] [Related]
15. Fos-related activator-1 is overexpressed in oral squamous cell carcinoma and associated with tumor lymph node metastasis.
Zhang L; Pan HY; Zhong LP; Wei KJ; Yang X; Li J; Shen GF; Zhang Z
J Oral Pathol Med; 2010 Jul; 39(6):470-6. PubMed ID: 20149058
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of Annexin A1 correlates with pathologic differentiation grade in oral squamous cell carcinoma.
Zhang L; Yang X; Zhong LP; Zhou XJ; Pan HY; Wei KJ; Li J; Chen WT; Zhang ZY
J Oral Pathol Med; 2009 Apr; 38(4):362-70. PubMed ID: 18673418
[TBL] [Abstract][Full Text] [Related]
17. X-Linked inhibitor of apoptosis protein expression level in colorectal cancer is regulated by hepatocyte growth factor/C-met pathway via Akt signaling.
Takeuchi H; Kim J; Fujimoto A; Umetani N; Mori T; Bilchik A; Turner R; Tran A; Kuo C; Hoon DS
Clin Cancer Res; 2005 Nov; 11(21):7621-8. PubMed ID: 16278380
[TBL] [Abstract][Full Text] [Related]
18. Expression of Wilms' tumor 1 (WT1) in oral squamous cell carcinoma.
Mikami T; Hada T; Chosa N; Ishisaki A; Mizuki H; Takeda Y
J Oral Pathol Med; 2013 Feb; 42(2):133-9. PubMed ID: 22672247
[TBL] [Abstract][Full Text] [Related]
19. TRB3 overexpression due to endoplasmic reticulum stress inhibits AKT kinase activation of tongue squamous cell carcinoma.
Zhang J; Wen HJ; Guo ZM; Zeng MS; Li MZ; Jiang YE; He XG; Sun CZ
Oral Oncol; 2011 Oct; 47(10):934-9. PubMed ID: 21821462
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of a serine-threonine kinase proto-oncogene Pim-1 in oral squamous cell carcinoma.
Chiang WF; Yen CY; Lin CN; Liaw GA; Chiu CT; Hsia YJ; Liu SY
Int J Oral Maxillofac Surg; 2006 Aug; 35(8):740-5. PubMed ID: 16546353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
